Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Aug 30;8:391.
doi: 10.1186/s13104-015-1378-3.

Vitamin D Supplementation to Patients With Frequent Respiratory Tract Infections: A Post Hoc Analysis of a Randomized and Placebo-Controlled Trial

Affiliations
Free PMC article
Randomized Controlled Trial

Vitamin D Supplementation to Patients With Frequent Respiratory Tract Infections: A Post Hoc Analysis of a Randomized and Placebo-Controlled Trial

Peter Bergman et al. BMC Res Notes. .
Free PMC article

Abstract

Background: Vitamin D is considered to be important for a healthy immune system. The aim of this study was to test the hypothesis that vitamin D supplementation reduces number of respiratory tract infections (RTIs) and prolong the time to the first RTI in adult patients with frequent RTIs.

Methods: We performed a post hoc analysis of a randomized, placebo-controlled and double-blinded study, where adult patients with a high burden of RTIs were randomized to placebo or vitamin D (4000 IE/day for 1 year, n = 124 in the per protocol cohort presented here).

Results: Vitamin D supplementation increased the probability to stay free of RTI during the study year (RR 0.64, 95% CI 0.43-0.94). Further, the total number of RTIs was also reduced in the vitamin D-group (86 RTIs) versus placebo (120 RTIs; p = 0.05). Finally, the time to the first RTI was significantly extended in the vitamin D-group (HR 1.68, 95% CI 1.03-2.68, p = 0.0376).

Conclusion: Vitamin D supplementation was found to significantly increase the probability of staying infection free during the study period. This finding further supports the notion that vitamin D-status should be monitored in adult patients with frequent RTIs and suggests that selected patients with vitamin D deficiency are supplemented. This could be a safe and cheap way to reduce RTIs and improve health in this vulnerable patient population. The original trial was registered at http://www.clinicaltrials.gov (NCT01131858).

Figures

Fig. 1
Fig. 1
Time to first acute respiratory tract infection (RTI) in immunodeficient patients treated with vitamin D (4000 IE/day for 1 year) or placebo. There was a significantly higher probability to stay infection free in the vitamin D-group (HR 1.68, 95 % CI 1.03–2.68, p = 0.038, Log rank Mantel Cox test)

Similar articles

See all similar articles

Cited by 5 articles

References

    1. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, Tavera-Mendoza L, Lin R, Hanrahan JW, Mader S, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173(5):2909–2912. doi: 10.4049/jimmunol.173.5.2909. - DOI - PubMed
    1. Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther. 2008;324(1):23–33. doi: 10.1124/jpet.107.127209. - DOI - PubMed
    1. Lemire JM, Archer DC, Beck L, Spiegelberg HL. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr. 1995;125(6 Suppl):1704S–1708S. - PubMed
    1. Gibney KB, MacGregor L, Leder K, Torresi J, Marshall C, Ebeling PR, Biggs BA. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin Infect Dis Off Publ Infect Dis Soc Am. 2008;46(3):443–446. doi: 10.1086/525268. - DOI - PubMed
    1. Martineau AR, Nhamoyebonde S, Oni T, Rangaka MX, Marais S, Bangani N, Tsekela R, Bashe L, de Azevedo V, Caldwell J, et al. Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa. Proc Natl Acad Sci USA. 2011;108(47):19013–19017. doi: 10.1073/pnas.1111825108. - DOI - PMC - PubMed

Publication types

Associated data

Feedback